Why Envoy Medical, Inc.’s (COCH) Stock Is Down 5.50%
As of Monday, August 17, Envoy Medical, Inc.’s COCH share price has dipped by 5.50%, which has investors questioning if this is right time to buy.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company’s medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Commentary & Analysis
Why Envoy Medical, Inc.’s (COCH) Stock Is Up 7.80%
As of Tuesday, August 11, Envoy Medical, Inc.’s COCH share price has surged by 7.80%, which has investors questioning if this is right time to sell.Michael Rose
Why Envoy Medical, Inc.’s (COCH) Stock Is Up 5.04%
As of Monday, August 10, Envoy Medical, Inc.’s COCH share price has surged by 5.04%, which has investors questioning if this is right time to sell.Michael Rose
Why Envoy Medical, Inc.’s (COCH) Stock Is Up 9.85%
As of Tuesday, July 21, Envoy Medical, Inc.’s COCH share price has surged by 9.85%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why Envoy Medical, Inc.’s (COCH) Stock Is Down 6.08%
As of Friday, July 17, Envoy Medical, Inc.’s COCH share price has dipped by 6.08%, which has investors questioning if this is right time to buy.Jenna Brashear
Financial Summary
| Share Statistics | COCH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $57.9 | $422.9 | 16% |
|
| Shares Out (Mil) | 104.0 | 41.4 | 63% |
|
| Institutional Ownership | 27.3% | 83.6% | 12% |
|
| Float (Mil) | 38.4 | 34.9 | 41% |
|
| Beta | 1.89 | 0.88 | 91% |
|
| Avg Daily Volume (000s) | 145 | 409 | 39% |
|
| Price Change (52-week) |
(41.0%) | 66.3% | 18% |
|
| Growth | COCH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.9% | na |
|
| Net Income (5yr) | na | (5.9%) | na |
|
| EPS (5yr) | na | 10.4% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (16.2%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | ($0.070) | ($0.295) | ($0.220) | |
| Month Ago EPS | ($0.070) | ($0.290) | ($0.190) | |
| # Rev Up | 0 | 1 | na | |
| # Rev Down | 1 | 1 | na | |
| Three Months Ago EPS | ($0.060) | ($0.300) | na | |
| Year/Year Chg | 0.0% | (76.1%) | (81.3%) | |
| Financials | COCH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $0 | $123 | 0% |
|
| Net Income (TTM) (Mil) | ($23) | ($9) | 22% |
|
| EPS (TTM) | ($0.509) | ($0.400) | 27% |
|
| Operating Cash Flow (TTM) (Mil) | ($22) | ($3) | 14% |
|
| Net Cash Flow (TTM) (Mil) | na | $1 | na |
|
| Long-Term Debt (Q1) (Mil) | $1 | $22 | 16% |
|
| Enterprise Value (Q1) (Mil) | $38 | $418 | 15% |
|
| Valuation | COCH | Industry Median |
Percentile (All Stocks) |
|
| P/B | 15.00 | 3.13 | 93% |
|
| P/E | na | 28.1 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.7 | na |
|
| Ratios | COCH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | (293.7%) | 58.7% | 1% |
|
| Net Margin | na | (6.9%) | na |
|
| ROA | (138.3%) | (12.3%) | 4% |
|
| ROE | 178.9% | (12.3%) | 98% |
|
| Liabilities to Assets | 84.6% | 46.0% | 78% |
|
| F-Score | 4 | 4 | 33% |
|
Envoy Medical, Inc. did not pass any screens on 8/21/2026.
